Immune Checkpoint Inhibition in Pediatric Oncology Patients: A Single-Institution Experience
Immunotherapy has emerged as a promising treatment approach in oncology, as it is specifically designed to boost the strength and accuracy of the immune system, allowing it to target tumor cells but spare non-tumor tissue. This treatment not only demonstrates potential for improved clinical outcomes...
שמור ב:
| Principais autores: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2024-03-01
|
| סדרה: | Hemato |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2673-6357/5/1/7 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|